The chokepoint fact first: EUV lithography is the most expensive step in chipmaking, and anything that wastes EUV light is a direct tax on cost and throughput. US11656544B2, granted May 2023 to TSMC, patents a robust, high-transmission pellicle for EUV systems (CPC G03F 1/64).
Gloss it once. A pellicle is a thin film stretched over the photomask to keep particles off the pattern. In EUV, the light is generated at enormous cost and any absorption by the pellicle reduces how much reaches the wafer — cutting throughput and raising cost per wafer. So a pellicle that is both durable and highly transmissive is a real economic lever, not a minor accessory.
Why a chokepoint read cares: EUV capacity is constrained by ASML's monopoly on the scanners, but throughput at each scanner is constrained by exactly these consumables. Improving pellicle transmission squeezes more good wafers out of fixed, scarce EUV capacity — which is why a leading foundry patents it.
The period framing matters. By 2023, EUV was firmly in volume production at the leading edge, and the industry's attention was turning to efficiency at the tool. A high-transmission pellicle patent reflects that shift from securing EUV access to maximizing EUV yield.
The caveat we attach: this is a consumable-and-materials patent and a defensive asset. It evidences TSMC's focus on EUV efficiency; it does not quantify the throughput gain or prove deployment.
For the period investor, the durable point is that the EUV chokepoint has two layers — access to the scanners and efficiency on them. A 2023 pellicle grant addresses the second, quieter layer of that constraint.